Influence of Antiseptic Washes on Wound Healing Complications After THA (NCT07104084)
Comparison of Wound Healing Complications After Anterior Total Hip Arthroplasty Using Povidone-iodine or Chlorhexidine as Antiseptic Wash
π©Ί Plain-English Summary (8th-Grade Level)
The purpose of this research trial is to evaluate the effect of two types of washing solutions on wound healing after total hip replacement surgery. Washing solutions are used routinely during total hip replacements to clean the wound after the components have been placed and the wound is about to be closed with sutures. It is currently not known which washing solution may be better for wound healing and whether a certain solution decreases the risk of wound healing complications after total hip replacement. Therefore, this research trial is being conducted. Study participants will be randomized into one of two groups: washing the surgical wound with povidone-iodine solution (Surgiphor, Becton Dickinson, Franklin Lakes, NJ) or chlorhexidine solution (Irrisept, Irrimax Corporation, Lawrenceville, GA). All patients will undergo standard of care total hip replacements without any other change in surgery. The best type of solution that cleans the wound and potentially leads to better wound healing is unknown. This study will evaluate whether there is difference in surgical wound healing between the two washing solutions. The study will pay for the washing solutions. Patients will follow up for standard postoperative visits. At the 2-week and 6-week visits, pictures of the surgical incision will be taken and saved in the electronic medical record and evaluated in a standardized way for healing of the incision and the appearance of the scar. Postoperative complications and returns to the hospital or additional surgeries will be collected from the electronic medical record.
Who can join: Review the eligibility criteria below.
Location: UPMC East β Monroeville, Pennsylvania
Age range: 18 Years
π§ͺ Interventions in This Study
π "Do I Qualify?" β 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria β
π All Participating Trial Locations (2 Sites)
- UPMC East β Monroeville, Pennsylvania
- UPMC Shadyside β Pittsburgh, Pennsylvania
π Contact the Study Coordinator
Phone: (412) 687-3900
Email: platefj2@upmc.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
π° Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Hip Osteoarthritis
- Positioning for Hip Arthroscopic Surgery to Reduce Postoperative Numbness β Chicago, Illinois
- REDAPT Revision Hip System With RSA β Winnipeg, Manitoba
- Insigniaβ’ Hip Stem Outcomes Study β Phoenix, Arizona
- Prospective Catalystem CT-RSA β Winnipeg, Manitoba
- Alexis Retractor in Total Hip Arthroplasty β Miami, Florida
- Bone Marrow Aspirate Concentrate Versus Triamcinolone Injection For Hip Osteoarthritis β Weston, Florida
Explore by condition: All Hip Osteoarthritis clinical trials
π‘ How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.